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• Review the peculiarities in the energy metabolism of cancer cells (Warburg effect). 
• Review of the different inhibitors of this pathway, and combinations with other therapeutic methods of 
cancer treatment. 
AIMS 
• There are many causes that can lead to the establishment of the Warburg effect on malignant cells, but 
the consequence is always a dependence of the glycolytic pathway to generate ATP. Therefore, an 
inhibition of this pathway may end with cancer cells.    
• Many drugs can block glycolysis, but without a full effectiveness in vivo. Because of it, we can use a 
combination of these drugs (to exhaust enough the cell) with other types of anticancer therapy 
(chemotherapy or radiotherapy). 
CONCLUSIONS 
•Cancer cell metabolism is characterized by an 
increased glycolysis to generate ATP, and this is 
due to mitochondrial defects, hypoxia, 
oncogenic signals and altered metabolic 
enzymes. Green arrows in figure 1 show how 
glycolytic pathway is enhanced. 
INCREASED AEROBIC GLYCOLYSIS 
IN CANCER CELLS 
Figure 1. Glycolytic pathway and its metabolic 
interconnection with the pentose phosphate pathway  and 
the Krebs cycle.  
• Since maintaining a high level of glycolysis is 
essential for cancer cells, an inhibition of this 
pathway may kill the malignant cells. Red 
arrows in figure 1 show the main drugs that 
inhibit glycolysis at different levels. 
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• Normal cells: 36 ATPs by 
glycolysis + OXPHOS.  
• Cancer cells: 2 ATPs just by 
glycolysis. 
INCREASED GLYCOLYTIC FLUX 
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•2 ATPs vs. 36 ATPs 
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Increased glycolytic flux in cancer cells: 36 
ATPs in normal cells (glycolysis + OXPHOS) 
vs. 2 ATPs in cancer cells (just by glycolysis) . 
•36 ATPs by glycolysis + OXPHOS. 
• 2 ATPs just by glycolysis. 
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